Wasif Aziz

Director Global Regulatory Affairs at Grünenthal Group - Worthington, IA, US

Wasif Aziz's Colleagues at Grünenthal Group
Christian Zelle

National Sales Director Retail

Contact Christian Zelle

Sabine Wiemer

Head of Business Unit Specialty Products

Contact Sabine Wiemer

Michael Finkam

Head Analytical Development

Contact Michael Finkam

Peter Dowideit

Head of Marketing & KAM Hospital

Contact Peter Dowideit

Thomas Kasberg

Senior Director Alliance Management

Contact Thomas Kasberg

Martin Petersen

External Innovation Lead, Clinical R&D Portfoliomanagement, Senior Director

Contact Martin Petersen

View All Wasif Aziz's Colleagues
Wasif Aziz's Contact Details
HQ
49-241-569-0
Location
Company
Grünenthal Group
Wasif Aziz's Company Details

Grünenthal Group

Worthington, IA, US • 1000 - 4999 Employees
Major Drugs

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://www.grunenthal.com/grt-web/Grunenthal_Group/Jobs-Career/Vacancies/134100187.jsp Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp

Europe: Pain (prescriptive drugs) Further indications Latin America: Pain Central Nervous System Gynecology Further indications R&D: Pain Inflammation
Details about Grünenthal Group
Frequently Asked Questions about Wasif Aziz
Wasif Aziz currently works for Grünenthal Group.
Wasif Aziz's role at Grünenthal Group is Director Global Regulatory Affairs.
Wasif Aziz's email address is ***@grunenthal.com. To view Wasif Aziz's full email address, please signup to ConnectPlex.
Wasif Aziz works in the Pharmaceuticals industry.
Wasif Aziz's colleagues at Grünenthal Group are Christian Zelle, Sabine Wiemer, Michael Finkam, Peter Dowideit, Thomas Kasberg, Michael Esser, Martin Petersen and others.
Wasif Aziz's phone number is 49-241-569-0
See more information about Wasif Aziz